INS and obesity disorder: In obesity, the IL-6 concentration increases, which decreases the sensitivity to insulin and increases glucose absorption in peripheral tissues [4,5,6], causing metabolic and cardiovascular diseases [7] and diabetes mellitus 2 [8,9].